Foresite Capital Fund V, L.P.'s Net Worth
$158 Million
Who is Foresite Capital Fund V, L.P.?
Foresite Capital Fund V, L.P. has an estimated net worth of $158 Million. This is based on reported shares across multiple companies, which include PARDES BIOSCIENCES, INC., Aclaris Therapeutics, Inc., Kinnate Biopharma Inc., Theseus Pharmaceuticals, Inc., and Gemini Therapeutics, Inc. /DE.
SEC CIK
Foresite Capital Fund V, L.P.'s CIK is 0001792204
Past Insider Trading and Trends
2021 was Foresite Capital Fund V, L.P.'s most active year for acquiring shares with 10 total transactions. Foresite Capital Fund V, L.P.'s most active month to acquire stocks was the month of November. 2020 was Foresite Capital Fund V, L.P.'s most active year for disposing of shares, totalling 9 transactions. Foresite Capital Fund V, L.P.'s most active month to dispose stocks was the month of November. 2021 saw Foresite Capital Fund V, L.P. paying a total of $34,275,000.00 for 24,013,598 shares, this is the most they've acquired in one year. In 2023 Foresite Capital Fund V, L.P. cashed out on 16,813,146 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.1398
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.58% | -1.95M |
—
|
—
| 8.28K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PARDES BIOSCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -99.99% | -16.81M |
—
|
—
| 1K |
Aug 31
| |||
Form 4
| +6.04% | 773.95K |
$1.50 | $1,160,928.00 | 13.58M |
Apr 5
| |||
Form 4
| +5.24% | 637.42K |
$0.85 | $541,807.00 | 12.81M |
Dec 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4/A
|
∞
| 4.94M |
—
|
—
| 4.94M |
Dec 23
| |||
Form 4
|
∞
| 13.63M |
$10.00 | $10,000,000.00 | 13.63M |
Dec 23
| |||
Form 4
|
∞
| 325K |
$10.00 | $3,250,000.00 | 325K |
Dec 22
| |||
Form 4
|
∞
| 602.5K |
$10.00 | $6,025,000.00 | 602.5K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.60% | 700K |
$2.97 | $2,079,000.00 | 5.49M |
Jul 17
| |||
Form 4
| +11.64% | 500K |
$5.00 | $2,500,000.00 | 4.79M |
Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $65.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.43M |
$10.00 | $15,000,000.00 | 4.43M |
Feb 5
| |||
Form 4
|
∞
| 441.5K |
$10.00 | $4,415,000.00 | 441.5K |
Aug 14
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.72M |
—
|
—
|
0
|
Apr 3
| |||
Form 4
| +78.53% | 1.78M |
$2.80 | $4,984,000.00 | 4.05M |
May 8
| |||
Form 4
| +125.71% | 1.1M |
—
|
—
| 1.98M |
Feb 17
| |||
Form 4
| +983.83% | 9.84M |
—
|
—
| 10.84M |
Dec 7
| |||
Form 4
|
∞
| 1M |
$20.00 | $20,000,000.00 | 1M |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||